I think the next big news have to be on the psoriasis front. They had awesome data and my guess would be that they're going to license this candidate before Phase III trials. Abbott would probably love to have this one. I see another deal in the $1 billion range.
buyout by nvs has become less likely than before eli lilly's partnership I am probably wrong but incy might trade in a range of 8-10 until either some positive or negative news comes out which probbly is not expected until march at the earliest.